ImmunoForge Competitors and Similar CompaniesClear all
ImmunoForge's competitors and similar companies include Ridgeline Therapeutics, Syndax Pharmaceuticals, AbilityPharma and OSE Immunotherapeutics.
 Syndax Pharmaceuticals Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy. |  AbilityPharma AbilityPharma (also known as Ability Pharmaceuticals) is a biopharmaceutical company developing drugs targeting cancer. |  OSE Immunotherapeutics OSE Immunotherapeutics is a biotechnology company that focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. | |||
Founding Date | Founding Date 2017 | Founding Date 2012 | Founding Date 2005 | Founding Date 2009 | Founding Date 2012 |
Type | Type Private | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations KR HQ King Of Prussia, US | Locations West University Place, US HQ | Locations Waltham, US HQ New York, US Waltham, US | Locations Barcelona, ES HQ Cerdanyola Del Vallès, ES | Locations Nantes, FR HQ Paris, FR |
Employees | Employees 4 | Employees 5 | Employees 358% decrease | Employees 23 | Employees 52 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.6 b | Valuation ($) N/A | Valuation ($) 239 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $172.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €69.9m (FY, 2024) |
Net income | Net income N/A | Net income N/A | Net income ($285.4m) (FY, 2025) | Net income N/A | Net income €37.4m (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Ridgeline Therapeutics
HQ
West University Place, US
Employees
5
Ridgeline Therapeutics is a biotechnology company engaged in drug discovery.
View companySyndax Pharmaceuticals
HQ
Waltham, US
Employees
35↓ 8% decrease
Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy.
View companyAbilityPharma
HQ
Barcelona, ES
Employees
23
AbilityPharma (also known as Ability Pharmaceuticals) is a biopharmaceutical company developing drugs targeting cancer.
View companyOSE Immunotherapeutics
HQ
Nantes, FR
Employees
52
OSE Immunotherapeutics is a biotechnology company that focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases.
View company